Isolation and characterization of chemical constituents from Chaerophyllum bulbosum roots and their enzyme inhibitory and antioxidant effects
Autor: | Mehmet Öztürk, Zeynep Molo, Ebru Deveci, Gülsen Tel-Çayan, Mehmet Emin Duru |
---|---|
Rok vydání: | 2021 |
Předmět: |
chemistry.chemical_classification
Chaerophyllum bulbosum Antioxidant Stigmasterol Chromatography biology 010405 organic chemistry medicine.medical_treatment Tyrosinase biology.organism_classification 01 natural sciences General Biochemistry Genetics and Molecular Biology 0104 chemical sciences 010404 medicinal & biomolecular chemistry chemistry.chemical_compound Enzyme chemistry medicine Chaerophyllum IC50 Butyrylcholinesterase |
Zdroj: | Zeitschrift für Naturforschung C. 77:1-9 |
ISSN: | 1865-7125 0939-5075 |
DOI: | 10.1515/znc-2021-0119 |
Popis: | Isolation and bioactive effects of the roots of Chaerophyllum bulbosum L. were firstly investigated herein. Enzyme (acetylcholinesterase, butyrylcholinesterase, urease, α-amylase, α-glucosidase, and tyrosinase) inhibitory effects of C. bulbosum root extracts were tested. Three known compounds, n-heptadecanyl eicosanoate (1), stigmasterol (2), and β-sitosterol-3-O-β-d-glucopyranoside (3) were isolated from C. bulbosum. Antioxidant and enzyme inhibitory effects of isolated compounds were investigated. The hexane extract (IC50: 349.58 ± 0.06 μg/mL) displayed a higher α-glucosidase inhibitory effect than the standard (IC50: 378.66 ± 0.14 μg/mL). The best inhibitory effect was found in compound 2 on AChE (46.40 ± 0.31%), BChE (56.41 ± 0.54%), and urease (92.47 ± 0.11%); compound 1 on α-amylase (22.27 ± 0.61%); and compound 3 on α-glucosidase (12.43 ± 0.25%) and tyrosinase (19.00 ± 0.16%). All isolated compounds showed moderate antioxidant effects in all assays. This study contributes to the therapeutic uses of Chaerophyllum roots and emphasizes the value of C. bulbosum species for the development of novel therapeutic agents. |
Databáze: | OpenAIRE |
Externí odkaz: |